Film has played a meaningful role in bringing psilocybin research and harm-reduction perspectives to wider audiences. Over the past decade, a wave of documentaries has examined psychedelics from clinical, cultural, and personal angles — giving researchers, patients, veterans, and indigenous practitioners a chance to speak in their own words. These films are not substitutes for peer-reviewed evidence, and they carry the limitations that come with any advocacy-adjacent format: selective editing, anecdotal framing, and the tendency to foreground remarkable outcomes rather than the full distribution of results. Approached with those caveats in mind, however, they offer accessible entry points into a field that can otherwise feel locked behind academic paywalls and specialist jargon. This guide describes the most widely viewed and educationally relevant titles, organized by emphasis.
Clinical and Research Documentaries
Magic Medicine (2018)
Directed by Monty Wates, this British documentary provides rare inside access to the first UK clinical trial of psilocybin for treatment-resistant depression, conducted at Imperial College London under the supervision of Dr. Robin Carhart-Harris and Professor David Nutt. The film follows a small cohort of patients through screening, dosing sessions, and follow-up, capturing both the therapeutic promise and the psychological difficulty of the process. It is notable for showing the clinical environment honestly: the preparation, the licensed therapist presence, and the individual variation in how patients respond. For anyone seeking to understand what a supervised psilocybin session actually looks like in a research context, this film is among the most informative available. Caveat: the trial was small (n=20), and the film covers only select participants.
Neurons to Nirvana: Understanding Psychedelic Medicines (2013)
This Canadian documentary, directed by Oliver Hockenhull, examines the therapeutic potential of five psychedelic substances: LSD, MDMA, psilocybin, ayahuasca, and cannabis. Featuring interviews with leading researchers including Rick Doblin (founder of MAPS), Professor David Nutt, Dr. Roland Griffiths (Johns Hopkins), and Dr. Gabor Mate, the film builds a broad evidence-based case for revisiting the medical prohibition of these compounds. The psilocybin sections address depression, anxiety, and end-of-life distress research in particular depth. The film's strength is its density of expert voices; the limitation is that some of the clinical trial data it references was preliminary at the time of release. As context for the current research landscape, it remains a useful introduction.
Cultural and Personal Story Documentaries
Fantastic Fungi (2019)
Directed by Louie Schwartzberg, this is the most widely watched documentary in this genre and has introduced psilocybin to audiences who had no prior interest in psychedelics. The film centres on mycologist Paul Stamets and features an extended interview with author Michael Pollan, whose book How to Change Your Mind had already generated mainstream interest in psilocybin research. The documentary covers the ecological role of fungi, the history of psilocybin use, and the emerging science of therapeutic applications, while using time-lapse cinematography to render fungal growth visually. It is explicitly enthusiastic in tone and is better described as an introduction and advocacy piece than a balanced scientific overview. Available on Netflix. For viewers new to the subject, it is an effective first stop; for those seeking critical analysis, it should be followed by primary sources.
Dosed (2019) and Dosed 2: The Trip of a Lifetime (2022)
This Canadian two-part series, directed by Tyler Chandler, takes a direct harm-reduction approach that distinguishes it from most films in this space. The first film follows a woman named Adrianne struggling with heroin addiction who turns to psilocybin mushrooms as an alternative treatment after conventional options have failed. The second follows a woman with terminal cancer who uses psilocybin to address end-of-life anxiety. Both films document real people making real decisions about drug use outside clinical settings, which gives them a practical relevance to harm-reduction education that more polished productions lack. The series does not romanticize the process — both subjects experience difficulty — and includes honest discussion of risks, set and setting, and the absence of formal support structures. These are among the most directly relevant documentaries for understanding psilocybin use in real-world, non-clinical contexts.
From Shock to Awe (2018)
Directed by Luc Côté and Janine Sagert, this documentary focuses on US military veterans with PTSD who travel to retreat settings in Mexico and Peru to use plant medicines, including psilocybin, ayahuasca, and ibogaine, as alternatives to pharmaceutical treatment. The film does not minimize the severity of PTSD or the risks of the substances involved, and it situates psychedelic use within the veterans' ongoing therapeutic relationships. Its relevance to harm-reduction audiences is its examination of why individuals seek out unregulated treatment contexts when clinical options are unavailable or have been exhausted, and what structures of support matter most in those situations.
The Last Shaman (2016)
Directed by Raz Degan, this documentary follows a young American man whose family takes him to the Amazon for an extended ayahuasca healing process after conventional psychiatric treatment has failed to address his depression. The film is focused on ayahuasca rather than psilocybin directly, but provides important cultural and historical context for the broader tradition of plant medicine use — including the indigenous ceremonial frameworks within which psilocybin mushrooms have been used for centuries in Mesoamerica. Understanding that lineage is part of understanding why contemporary psilocybin research draws so heavily on set, setting, and intentionality rather than treating the compound in isolation. The film also raises honest questions about whether Western seekers can meaningfully access healing frameworks rooted in cultures not their own.
Entertainment-Adjacent Documentaries
Have a Good Trip: Adventures in Psychedelics (2020)
This Netflix production, directed by Donick Cary, takes a lighter approach than the other films on this list: it is primarily a collection of celebrity accounts of psychedelic experiences, combined with animation and comedic re-enactments. Scientists including Dr. Charles Grob of Harbor-UCLA Medical Center appear to provide context, and the film includes harm-reduction messaging around set, setting, and dosage. Its value as an educational resource is limited compared to the clinical and personal-narrative documentaries above, but it has reached a very large audience and for some viewers serves as an accessible first introduction. It is best understood as entertainment that occasionally intersects with education rather than the reverse.
Viewing Critically
Documentary film is a persuasive medium. Every film listed above has a point of view, and most were made by people sympathetic to psychedelic research or use. That does not make them unreliable, but it does mean they should be read alongside other sources rather than treated as authoritative. Specific things to watch for include:
- Sample sizes: clinical trials featured in documentaries are often small. Results that look compelling in film may not hold in larger, randomized controlled trials.
- Selection bias: documentary subjects are typically people who had positive or dramatic outcomes. People for whom psilocybin was unhelpful, neutral, or destabilizing are rarely given screen time.
- Missing context: films rarely discuss contraindications, the importance of screening for personal or family history of psychosis, or the potential for difficult psychological experiences that do not resolve positively.
- Regulatory status: the legal situation in most jurisdictions is not prominently addressed in these films. Viewers should not infer that any use depicted is legal in their location.
For peer-reviewed evidence, the primary sources are journals including JAMA Psychiatry, The Lancet Psychiatry, Neuropsychopharmacology, and Psychopharmacology. The Johns Hopkins Center for Psychedelic and Consciousness Research and the Imperial College Centre for Psychedelic Research both maintain public-facing pages summarizing their current work.
Where to Watch
Fantastic Fungi and Have a Good Trip are both available on Netflix. Neurons to Nirvana and Dosed have been available on Vimeo on Demand and through their respective official websites. Magic Medicine has screened at festivals and been distributed through Vimeo. From Shock to Awe and The Last Shaman have had varying streaming availability across platforms including Amazon Prime Video and dedicated documentary streaming services such as Documentary+. Availability changes over time, so searching the film title directly will give the most current options. Several of these films have also been screened at harm-reduction conferences, psychedelic research symposia, and community events, where they are sometimes followed by structured discussion with researchers or clinicians.